跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 253 条关于
“Pharmasyntez-Tyumen”
全部
253
临床试验
212
药物
11
机构
11
资讯
19
2个月前
R-Opra launches full-cycle production of AbbVie's paricalcitol generic Dekalpar for chronic kidney disease in Moscow
去年
Pharmasyntez to Launch Three Innovative Drugs with Blockbuster Potential in 2025-2026
3个月前
Orchid Pharma Enters Russia Licensing Pact for Novel Antibiotic Exblifep, US Deal in Advanced Talks
上个月
Kazakhstan Registers Promomed's Tirzetta as First Officially Available Tirzepatide Drug in the Country
去年
Acumen Pharmaceuticals Advances Sabirnetug in Alzheimer's Disease Treatment
去年
Acumen Pharmaceuticals' pTau217 Assay Streamlines Alzheimer's Clinical Trials
去年
Acumen Pharmaceuticals Advances Sabirnetug for Alzheimer's, Reports Q3 2024 Financials
去年
Acumen's Sabirnetug Shows Promise in Phase 1 Alzheimer's Trial
去年
Acumen and NKGen Present Alzheimer's Research at CTAD 2024
去年
Acumen and Lonza Expand Collaboration to Advance Sabirnetug for Alzheimer's Disease
第 1 页,共 2 页
上一页
下一页